Tiziana Life Sciences Ltd
TLSA
$2.03
-$0.10-4.70%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.82M | -2.82M | -3.60M | -3.60M | -2.33M |
| Total Depreciation and Amortization | 44.00K | 44.00K | 31.00K | 31.00K | 31.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 208.50K | 208.50K | 3.73M | 3.73M | 1.65M |
| Change in Net Operating Assets | -848.00K | -848.00K | -1.12M | -1.12M | 842.00K |
| Cash from Operations | -3.41M | -3.41M | -963.00K | -963.00K | 200.00K |
| Capital Expenditure | -3.00K | -3.00K | -2.50K | -2.50K | -7.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1.44M | 1.44M | -- | -- | -- |
| Cash from Investing | 1.44M | 1.44M | -2.50K | -2.50K | -7.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -24.00K | -24.00K | -36.00K | -36.00K | -34.50K |
| Issuance of Common Stock | 3.70M | 3.70M | 2.32M | 2.32M | -- |
| Repurchase of Common Stock | -- | -- | -26.00K | -26.00K | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 3.68M | 3.68M | 2.26M | 2.26M | -34.50K |
| Foreign Exchange rate Adjustments | 55.00K | 55.00K | 1.50K | 1.50K | -185.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.76M | 1.76M | 1.30M | 1.30M | -26.50K |